title: [Myocardial perfusion scintigraphy. Exact and cost-effective coronary disease imaging--secondary publication].
abstract: Mortality rates due to coronary arterial disease (CAD) have declined as result of improved prevention, diagnosis and management, but CAD remains the leading cause of death. Myocardial perfusion scintigraphy (MPS) provides a cost-effective tool for early detection of CAD in symptomatic individuals and can stratify patients according to risk of cardiac events. MPS also provides valuable information to assist clinical decision-making. A large body of evidence supports the current applications of MPS, which has become integral to several guidelines for clinical practice.
authors.affiliation: Rigshospitalet, Klinik for Klinisk Fysiologi og Nuklearmedicin og PET, og Frederiksberg Hospital, Afdeling for Klinisk Fysiologi og Nuklearmedicin. bhesse@rh.regionh.dk
authors.forename: Birger
authors.initials: B
authors.lastname: Hesse
authors.forename: Claus Leth
authors.initials: CL
authors.lastname: Petersen
authors.forename: Claudio
authors.initials: C
authors.lastname: Marcassa
authors.forename: Jeroen J
authors.initials: JJ
authors.lastname: Bax
authors.forename: Frank
authors.initials: F
authors.lastname: Bengel
authors.forename: Eliana
authors.initials: E
authors.lastname: Reyes
authors.forename: Richard
authors.initials: R
authors.lastname: Underwood
mesh_terms: D054058:Acute Coronary Syndrome / Q000000981:diagnostic imaging / Q000401:mortality; D003324:Coronary Artery Disease / Q000000981:diagnostic imaging* / Q000401:mortality; D003362:Cost-Benefit Analysis; D019317:Evidence-Based Medicine; D006801:Humans; D049268:Positron-Emission Tomography; D011379:Prognosis; D015899:Tomography, Emission-Computed, Single-Photon